HOPKINTON, Mass., Jan. 21 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of life sciences tools, announced today that TIME Magazine's no. 4 Top Scientific Discovery of 2009 included an integrated robotic system designed by Caliper's Automation, Consulting, Engineering, & Services (ACES) team.
Conceived by Dr. Ross King at Aberystwyth University in Wales, the integrated robotic system known as 'Adam, the Robot Scientist,' identified the role and function of nearly a dozen previously uncharacterized yeast genes. This achievement, initially published in the journal Science, marks the first time a robot with virtually no human intervention completed the cycle of the scientific method: formulation of a hypothesis, experimental design and execution, data interpretation, followed by revision of the original hypothesis.
"This outstanding achievement highlights the potential of laboratory automation," said Kevin Hrusovsky, CEO of Caliper Life Sciences. "Our ACES team is uniquely capable of designing and building solutions to meet and exceed the most complex requirements. As a pioneer in laboratory automation, Caliper has a long history of helping researchers improve laboratory efficiency and shape the future of scientific discovery."
With thousands of successful Caliper systems throughout the world and decades of experience, the ACES team, which includes some of the industry's most dedicated and talented engineers and scientists, is committed to a customer-centric approach to solution design. By focusing on a customer's unique needs and leveraging decades of experience in robotic integration, software development, assay design, and project management, Caliper designs and builds each system to meet the needs and exceed the expectations of each customer.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results, enabling the translation of those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.
SOURCE Caliper Life Sciences, Inc.